home / stock / soly / soly news

SOLY News and Press, Soliton Inc. From 11/05/19

Stock Information
Company Name: Soliton Inc.
Stock Symbol: SOLY
Market: NYSE
Website: soliton.com
Menu
SOLY SOLY Quote SOLY Short SOLY News SOLY Articles SOLY Message Board
Get SOLY Alerts

News, Short Squeeze, Breakout and More Instantly...
SOLY - Soliton Completes Treatment of All Patients in Pivotal Cellulite Trial

HOUSTON , Nov. 5, 2019 /PRNewswire/ -- Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary platform technology licensed from The University of Texas on behalf of the MD Anderson Cancer Center ("MD Anderson"), today...
SOLY - Soliton's Recent Positive Data Increases Potential Fibrotic Indications

HOUSTON , Oct. 29, 2019 /PRNewswire/ -- Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary platform technology licensed from The University of Texas on behalf of the MD Anderson Cancer Center ("MD Anderson"), discussed ...

SOLY - Soliton up 2% premarket on positive RAP data

Soliton (NASDAQ: SOLY ) perks up  2%  premarket on light volume in reaction preliminary data from a proof-of-concept study assessing its Rapid Acoustic Pulse (RAP) device for the treatment of keloid and hypertrophic scars. The results were presented at the American Society for De...

SOLY - Soliton Announces Positive Interim Clinical Trial Results with 27% Average Reduction in Scar Volume From Single Non-Invasive Treatment

HOUSTON , Oct. 25, 2019 /PRNewswire/ -- Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary platform technology licensed from The University of Texas on behalf of the MD Anderson Cancer Center ("MD Anderson"), today released ...
SOLY - Soliton to Announce Keloid Trial Data on October 25, 2019 and Host Webcast at 5:30PM ET to Discuss Results

HOUSTON , Oct. 21, 2019 /PRNewswire/ -- Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary platform technology licensed from The University of Texas on behalf of the MD Anderson Cancer Center ("MD Anderson"), today a...

SOLY - NetworkNewsBreaks - Soliton, Inc. (NASDAQ: SOLY) Closes Private Placement of 485,250 Shares of Common Stock

Soliton (NASDAQ: SOLY), a medical device company with a novel and proprietary platform technology licensed from The University of Texas on behalf of the MD Anderson Cancer Center, has closed a private placement of 485,250 shares of common stock with certain institutional and accredited investo...

SOLY - Soliton's FDA Cleared RAP Device is Granted Two Additional Key Patents

HOUSTON , Oct. 15, 2019 /PRNewswire/ -- Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical technology company that has developed a new acoustic shockwave device, today announced that the Taiwan Intellectual Property Office had issued our patent entitled, "Taiwan Divisio...
SOLY - IPOs - Where Good Money Goes To Die

For an equity market that has hit all-time highs on multiple occasions during this year, one would think that investors would be salivating over IPOs for a chance to "get in from the beginning" and bidding them higher in the process. The reality, though, is that IPOs have been one of the more ...

SOLY - Soliton announces $6.25M private placement

Soliton ( SOLY -1.4% ) has entered into definitive agreements with certain institutional investors to raise aggregate gross proceeds of ~$6.25M through the private placement of its equity securities. More news on: Soliton, Inc., Read more ...

SOLY - Soliton Announces $6.25 Million Private Placement

HOUSTON , Oct. 10, 2019 /PRNewswire/ -- Soliton, Inc. (NASDAQ: SOLY), a medical device company with a novel and proprietary platform technology licensed from The University of Texas on behalf of the MD Anderson Cancer Center ("MD Anderson"), today announced that it has entered into defi...
Previous 10 Next 10